However, the report pointed out that the best case scenario for the patient still comes at a cost: “Even cancer-free survivors must cope with the long-term effects of treatment that affect treatment and quality of life, as well as psychological concerns, such as fear of recurrence.”
Today, the five most common cancer types in women are breast (41 percent), uterine (8 percent), colorectal (8 percent), melanoma (7 percent) and thyroid (6 percent).
For men, the most common are prostate (43 percent), colorectal (9 percent), melanoma (8 percent), urinary bladder (7 percent) and non-Hodgkin's lymphoma (4 percent).
National Institutes of Health data modeling into 2024 show little percentage of change for either sex among these cancer types, although the number of survivors should increase.
Lung cancer, whose survival is ranked at eighth among U.S. men and women, is likely to remain among the most deadly cancer type, the report said. However, promising new therapies expected to be available in the next few years will renew hope for some patients.
The report did not include basal cell and squamous cell skin cancers, or carcinoma in situ (non-invasive cancer) of any site except urinary bladder in its cancer survivor totals.
Lynette Summerill is an award-winning writer and watersports junkie living in San Diego. In addition to writing about cancer for EmpowHER, her work has been seen in publications internationally.
Cancer Treatment & Survivorship Facts & Figures, 2014-2015. American Cancer Society.
Cancer Screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening. Otis W. Brawley et al. CA: A Cancer Journal for Clinicians, 64:1: pp30–51, January/February 2014.
More Americans Surviving Cancer than Ever. Jessica Firger. CBS News. June 2, 2014.
Reviewed July 8, 2014
by Michele Blacksberg RN
Edited by Jody Smith